The Korean Journal of Gastroenterology (대한소화기학회지)

The Korean Society of Gastroenterology (대한소화기학회)
권호 표지
DOI QR코드

DOI QR Code

Malignant Transformation of Inflammatory Hepatocellular Adenoma into Hepatocellular Carcinoma

염증성 간세포선종에서 발생한 원발성 간세포암종

  • Lee, Young Ju (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Joo, Jin Woo (Department of Pathology, Yonsei University College of Medicine) ;
  • Park, Jun Yong (Department of Internal Medicine, Yonsei University College of Medicine)
  • 이영주 (연세대학교 의과대학 내과학교실) ;
  • 주진우 (연세대학교 의과대학 병리학교실) ;
  • 박준용 (연세대학교 의과대학 내과학교실)
  • Published : 2018.11.25
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol 2014;11:737-749. https://doi.org/10.1038/nrgastro.2014.151
  2. Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of hepatocellular adenoma: recent advances. Clin Gastroenterol Hepatol 2015;13:1221-1230. https://doi.org/10.1016/j.cgh.2014.05.023
  3. Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010;12:509-522. https://doi.org/10.1111/j.1477-2574.2010.00222.x
  4. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001;21:877-892. https://doi.org/10.1148/radiographics.21.4.g01jl04877
  5. Arif-Tiwari H, Kalb B, Chundru S, et al. MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol 2014;20:209-221. https://doi.org/10.5152/dir.2014.13370
  6. Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50:481-489. https://doi.org/10.1002/hep.22995
  7. Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46:740-748. https://doi.org/10.1002/hep.21743
  8. Farges O, Ferreira N, Dokmak S, Belghiti J, Bedossa P, Paradis V. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011;60:85-89. https://doi.org/10.1136/gut.2010.222109
  9. Atwell TD, Brandhagen DJ, Charboneau JW, Nagorney DM, Callstrom MR, Farrell MA. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am J Roentgenol 2005;184:828-831. https://doi.org/10.2214/ajr.184.3.01840828
  10. Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 2006;26:433-438. https://doi.org/10.1111/j.1478-3231.2006.01244.x